Inhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe Hypertriglyceridemia-Reference-Cited by-同舟云学术

Inhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe Hypertriglyceridemia

Published:2021-07 Issue:2 Volume:78 Page:193-195
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Ahmad Zahid,Pordy Robert,Rader Daniel J.,Gaudet Daniel,Ali Shazia,Gonzaga-Jauregui Claudia,Ponda Manish P.,Shumel Brad,Banerjee Poulabi,Dunbar Richard L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference4 articles.

1. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;J Am Coll Cardiol,2019

2. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia;Musunuru;N Engl J Med,2010

3. ANGPTL3 inhibition in homozygous familial hypercholesterolemia;Gaudet;N Engl J Med,2017

4. Inhibition of angiopoietin-like protein 3 with a monoclonal antibody reduces triglycerides in hypertriglyceridemia;Ahmad;Circulation,2019

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New approaches to triglyceride reduction: Is there any hope left?;American Journal of Preventive Cardiology;2024-06

2. Hypercholesterolemia: a literature review on management using tafolecimab: a novel member of PCSK9 monoclonal antibodies;Annals of Medicine & Surgery;2024-03-12

3. L’évinacumab : un nouveau médicament dans l’arsenal thérapeutique de l’hypercholestérolémie réfractaire;Archives des Maladies du Coeur et des Vaisseaux - Pratique;2024-03

4. Residual cardiovascular risk: When should we treat it?;European Journal of Internal Medicine;2024-02

5. How to Handle Elevated Triglycerides: Life after PROMINENT;Current Atherosclerosis Reports;2023-12